Skip to main content
. 2018 Apr 5;315(2):L133–L148. doi: 10.1152/ajplung.00557.2017

Table 4.

CMAP Compounds that reversed signature 1

Rank Drug Condition (Reference) Classification/Use
6076 Etofylline Asthma (94) Bronchodilator
6077 (−)-Atenolol Beta adrenergic receptor antagonist
6078 Mevalolactone Chemical compound
6079 Ornidazole Antiprotozoal
6080 Solasodine Alkaloid
6081 Flunisolide Asthma* (20) Glucocorticoid
6082 Etacrynic acid Bronchoconstriction (63) Diuretic
6083 Tanespimycin HSP90 inhibitor
6084 Etamivan Asthma (83) Respiratory stimulant
6085 Solanine Alkaloid
6086 Procaine Asthma (80) Local anesthetic
6087 Ciprofloxacin Antibiotic
6088 Valproic acid Hyperresponsiveness (68) Anticonvulsant
6089 Alvespimycin HSP90 inhibitor
6090 Isoetarine Asthma* (45) Bronchodilator
6091 Valproic acid Hyperresponsiveness (68) Anticonvulsant
6092 Wortmannin Hyperresponsiveness (26) Phosphatidylinositol 3-kinase inhibitor
6093 Furaltadone Antibiotic
6094 Sirolimus Asthma (54) Immunosuppressant
6095 Oxymetazoline Asthma (35) Decongestant
6096 Homatropine Anticholinergic
6097 Urapidil Bronchospasm (53) Antihypertensive
6098 Minocycline Asthma (19) Antibiotic
6099 Estriol Estradiol metabolite
6100 Spironolactone Diuretic

Rank is order of correlation. CMAP, connectivity map; HSP, heat shock protein.

*

Approved for clinical treatment of asthma.